Filing Flows

Filing Flows › SHF Holdings (SHFS) › Guidance & outlook

SHF Holdings (SHFS) guidance and outlook

SHF Holdings' 10-Q filed Nov 9, 2026 makes 21 forward-looking statements.

Guidance and outlook

SHF Holdings: what its forward-looking statements are about (10-Q filed 2026-11-09)SHF Holdings: what its forward-looking statements are about (10-Q filed 2026-11-09)Other7Legal & regulation5Costs4Financing2Products1Supply chain1Demand1
21 statements; tone +0.19 (−1 all cautious, +1 all confident); 5 hedged.
SHF Holdings: outlook statements against the filing beforeSHF Holdings: outlook statements against the filing beforeConfident6Cautious2

Forward-looking statements, 10-Q filed Nov 9, 2026

SHF Holdings' latest quarter

SHF Holdings, Q3 2026: revenue $2.0M (+6% year over year), operating margin -51.3%, net loss $979K, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.

Questions

What does SHF Holdings expect?

Instead, we provide compliance monitoring, onboarding, and reporting services that allow our financial institution clients to accept and maintain CRB deposit accounts in a manner consistent with Bank Secrecy Act (“BSA”) requirements, FinCEN guidance, and applicable anti-money laundering regulations. On June 17, 2026, Nasdaq published guidance on the Nasdaq Listing Center (identification number 1877) stating that state-licensed medical marijuana companies that register with the DEA and operate in compliance with federal law are eligible to list on Nasdaq if they can provide an opinion of counse

Open the interactive view →

Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.